Apomorphine – March 2020

Apomorphine: Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 ml, Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 ml pre-filled pen; Apomine® Solution for infusion and Apomine® Intermittent

Brand names:
- Apomine® Solution for Infusion
- Apomine® Intermittent
Pharmaceutical Company:
- Pfizer Australia Pty Ltd
Condition/Indication: Parkinson Disease
Meeting Date: March 2020
Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)

Last updated

3 July 2020